Characterization of a soluble nuclear ribonucleoprotein antigen reactive with SLE sera.
D000818:Animals; D000906:Antibodies / Q000032:analysis*; D000936:Antigen-Antibody Complex / Q000032:analysis; D000937:Antigen-Antibody Reactions; D000941:Antigens; D001853:Bone Marrow / Q000032:analysis / Q000276:immunology; D001854:Bone Marrow Cells; D002417:Cattle; D003168:Complement Fixation Tests; D003851:Deoxyribonucleases / Q000494:pharmacology; D005455:Fluorescent Antibody Technique; D006801:Humans; D007106:Immune Sera; D005779:Immunodiffusion; D007122:Immunoelectrophoresis; D007951:Leukemia, Myeloid / Q000276:immunology; D008180:Lupus Erythematosus, Systemic / Q000276:immunology*; D009698:Nucleoproteins; D010504:Periodic Acid / Q000494:pharmacology; D011233:Precipitin Tests; D012313:RNA; D011817:Rabbits; D012260:Ribonucleases / Q000494:pharmacology; D012266:Ribose / Q000032:analysis; D012964:Sodium / Q000494:pharmacology; D013154:Spleen / Q000032:analysis; D013945:Thymoma / Q000276:immunology; D013950:Thymus Gland / Q000032:analysis / Q000276:immunology; D014357:Trypsin / Q000494:pharmacology
D000906:Antibodies; D000936:Antigen-Antibody Complex; D000941:Antigens; D007106:Immune Sera; D009698:Nucleoproteins; D010504:Periodic Acid; D012313:RNA; D012266:Ribose; D012964:Sodium; D003851:Deoxyribonucleases; D012260:Ribonucleases; D014357:Trypsin